Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed250%
unknown125%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

Feasibility of the Menstrual Cup for VVF

NCT03414060
active_not_recruitingphase_2

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

NCT05666778
completednot_applicable

Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout

NCT03051789
unknown

Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)

NCT04059510

Clinical Trials (4)

Showing 4 of 4 trials
NCT03414060Not Applicable

Feasibility of the Menstrual Cup for VVF

Completed
NCT05666778Phase 2

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

Active Not Recruiting
NCT03051789Not Applicable

Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout

Completed
NCT04059510

Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4